Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study

BACKGROUND: Very few data regarding the use of infliximab in children with very early-onset inflammatory bowel disease (VEO-IBD) have been reported. OBJECTIVE: We aimed to assess the efficacy and the safety of infliximab in children with VEO-IBD compared with older children. METHODS: Children treate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:United European Gastroenterol J
Hlavní autoři: Bramuzzo, Matteo, Arrigo, Serena, Romano, Claudio, Filardi, Maria Chiara, Lionetti, Paolo, Agrusti, Anna, Dipasquale, Valeria, Paci, Monica, Zuin, Giovanna, Aloi, Marina, Strisciuglio, Caterina, Miele, Erasmo, Pastore, Maria, Martelossi, Stefano, Alvisi, Patrizia
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620882/
https://ncbi.nlm.nih.gov/pubmed/31316780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619847592
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky